DNGR-1 limits Flt3L-mediated antitumor immunity by restraining tumor-infiltrating type I conventional dendritic cells.
Cueto FJ, Del Fresno C, Brandi P, Combes AJ, Hernández-García E, Sánchez-Paulete AR, Enamorado M, Bromley CP, Gomez MJ, Conde-Garrosa R, Mañes S, Zelenay S, Melero I, Iborra S, Krummel MF, Sancho D.
Cueto FJ, et al. Among authors: del fresno c.
J Immunother Cancer. 2021 May;9(5):e002054. doi: 10.1136/jitc-2020-002054.
J Immunother Cancer. 2021.
PMID: 33980589
Free PMC article.